​

Baxter (BAX) Stock Forecast, Price Target & Predictions

OverviewRevenueOwnershipFinancialsChartTranscripts

BAX Stock Forecast

Baxter (BAX) stock forecast, based on 36 Wall Street analysts, predicts a 12-month average price target of $30.00, with a high of $36.00 and a low of $24.00. This represents a 29.48% increase from the last price of $23.17.

$20 $26 $32 $38 $44 $50 High: $36 Avg: $30 Low: $24 Last Closed Price: $23.17

BAX Stock Rating

Baxter stock's rating consensus is Hold, based on 36 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 15 Buy (41.67%), 20 Hold (55.56%), 1 Sell (2.78%), and 0 Strong Sell (0.00%).

Hold
Total 36 1 20 15 Strong Sell Sell Hold Buy Strong Buy

BAX Price Target Upside V Benchmarks

TypeNameUpside
StockBaxter29.48%
SectorHealthcare Stocks 15.45%
IndustryMedical Instruments & Supplies Stocks20.76%

Price Target Trends

1M3M12M
# Anlaysts-23
Avg Price Target-$30.00$34.00
Last Closing Price$23.17$23.17$23.17
Upside/Downside-29.48%46.74%
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Oct, 2513121-17
Sep, 2513121-17
Aug, 2514111-17
Jul, 2524111-18
Jun, 2524111-18
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Aug 04, 2025Barclays$36.00$22.4460.43%55.37%
Aug 04, 2025UBS$24.00$22.446.95%3.58%
Jan 02, 2025Vijay KumarEvercore ISI$42.00$29.2643.54%81.27%
Oct 04, 2024Travis SteedBank of America Securities$45.00$36.3223.90%94.22%
Aug 06, 2024Matthew TaylorJefferies$42.00$36.9213.76%81.27%
Jul 15, 2024Patrick WoodMorgan Stanley$30.00$35.32-15.06%29.48%
Jun 12, 2024David RomanGoldman Sachs$36.00$33.318.08%55.37%
May 03, 2024Danielle AntalffyUBS$40.00$36.918.37%72.64%
May 02, 2024Matthew TaylorJefferies$43.00$36.8916.56%85.58%
May 02, 2024Rick WiseStifel Nicolaus$44.00$36.7319.79%89.90%
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
Jul 31, 2025Goldman SachsNeutralNeutraldowngrade
Jan 02, 2025Evercore ISIOutperformOutperformhold
Sep 30, 2024Deutsche BankHoldHoldhold
Aug 06, 2024JefferiesHoldHoldhold
Jul 15, 2024Morgan StanleyEqual-WeightUnderweightdowngrade
Jun 12, 2024Goldman SachsNeutralNeutralhold
May 30, 2024Goldman SachsBuyNeutralinitialise
May 22, 2024CitigroupNeutralNeutralhold
May 10, 2024Cowen & Co.Sector WeightHolddowngrade
May 03, 2024UBSNeutralNeutralhold

Financial Forecast

EPS Forecast

$-5 $-2 $1 $4 $7 $10 Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$2.17$2.56$-4.80$5.25$-0.61----
Avg Forecast$3.06$3.60$3.56$2.59$1.83$2.47$2.72$3.15$3.40
High Forecast$3.07$3.62$3.60$2.60$1.84$2.54$2.83$3.20$3.46
Low Forecast$3.04$3.57$3.48$2.58$1.82$2.40$2.63$3.05$3.30
Surprise %-29.08%-28.89%-234.83%102.70%-133.33%----

Revenue Forecast

$0 $4B $8B $12B $16B $20B Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$11.67B$12.78B$15.11B$14.81B$4.51B----
Avg Forecast$11.58B$12.57B$15.00B$14.74B$10.56B$11.22B$11.71B$12.30B$12.84B
High Forecast$11.63B$12.63B$15.14B$14.82B$10.58B$11.34B$11.72B$12.33B$13.00B
Low Forecast$11.53B$12.51B$14.75B$14.72B$10.52B$11.00B$11.70B$12.27B$12.56B
Surprise %0.78%1.70%0.77%0.49%-57.25%----

Net Income Forecast

$-3B $-1B $-300M $800M $2B $3B Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$1.10B$1.28B$-2.42B$2.66B$-312.00M----
Avg Forecast$1.02B$1.17B$1.02B$-76.00M$924.32M$1.25B$1.38B$1.58B$1.72B
High Forecast$1.23B$1.40B$1.23B$-60.80M$929.37M$1.29B$1.43B$1.62B$1.75B
Low Forecast$817.34M$935.04M$818.87M$-91.20M$919.27M$1.21B$1.33B$1.55B$1.67B
Surprise %7.86%9.86%-336.52%-3594.74%-133.75%----

BAX Forecast FAQ

Is Baxter stock a buy?

Baxter stock has a consensus rating of Hold, based on 36 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 15 Buy, 20 Hold, 1 Sell, and 0 Strong Sell, reflecting a consensus that Baxter is a neutral investment for most analysts.

What is Baxter's price target?

Baxter's price target, set by 36 Wall Street analysts, averages $30 over the next 12 months. The price target range spans from $24 at the low end to $36 at the high end, suggesting a potential 29.48% change from the previous closing price of $23.17.

How does Baxter stock forecast compare to its benchmarks?

Baxter's stock forecast shows a 29.48% upside, outperforming the average forecast for the healthcare stocks sector (15.45%) and outperforming the medical instruments & supplies stocks industry (20.76%).

What is the breakdown of analyst ratings for Baxter over the past three months?

  • October 2025: 5.88% Strong Buy, 17.65% Buy, 70.59% Hold, 5.88% Sell, 0% Strong Sell.
  • September 2025: 5.88% Strong Buy, 17.65% Buy, 70.59% Hold, 5.88% Sell, 0% Strong Sell.
  • August 2025: 5.88% Strong Buy, 23.53% Buy, 64.71% Hold, 5.88% Sell, 0% Strong Sell.

What is Baxter’s EPS forecast?

Baxter's average annual EPS forecast for its fiscal year ending in December 2025 is $2.47, marking a -504.92% decrease from the reported $-0.61 in 2024. Estimates for the following years are $2.72 in 2026, $3.15 in 2027, and $3.4 in 2028.

What is Baxter’s revenue forecast?

Baxter's average annual revenue forecast for its fiscal year ending in December 2025 is $11.22B, reflecting a 148.70% increase from the reported $4.51B in 2024. The forecast for 2026 is $11.71B, followed by $12.3B for 2027, and $12.84B for 2028.

What is Baxter’s net income forecast?

Baxter's net income forecast for the fiscal year ending in December 2025 stands at $1.25B, representing a -500.63% decrease from the reported $-312M in 2024. Projections indicate $1.38B in 2026, $1.58B in 2027, and $1.72B in 2028.